Patents Assigned to Transcutaneous Technologies Inc.
-
Publication number: 20080154178Abstract: Systems, devices, and methods for powering and/or controlling electrically powered devices. A power supply system is operable to provide a voltage across at the active and the counter electrode assemblies of a transdermal delivery device. The system includes a power source and a magnetic coupling element.Type: ApplicationFiled: November 29, 2007Publication date: June 26, 2008Applicant: Transcutaneous Technologies Inc.Inventors: Darrick Carter, Joshua K. Hoyt, James Thorne, Forrest Seitz
-
Publication number: 20080077076Abstract: An iontophoresis device includes an active agent reservoir that stores a quantity of an active agent for delivery into a biological interface. An active electrode element is operable to apply an electric potential to deliver at least a portion of the active agent into the biological interface. A port is selectively coupled to a computing system to provide both information and power to the iontophoresis device.Type: ApplicationFiled: August 29, 2007Publication date: March 27, 2008Applicant: TRANSCUTANEOUS TECHNOLOGIES INC.Inventor: Darrick Carter
-
Publication number: 20080058701Abstract: A device for delivery of one or more active agents to a biological interface includes a matrix having at least one dendritic polymer or arborol. In certain embodiments, the dendritic polymer or arborol self-assembles to form a matrix having aqueous pores or cavities to contain and allow transport of active agents or ions. In particular aspects, the device is an iontophoretic device. In certain aspects, the iontophoretic device may include an active electrode assembly having an active agent holding portion or reservoir; and a non-active electrode assembly.Type: ApplicationFiled: July 3, 2007Publication date: March 6, 2008Applicant: TRANSCUTANEOUS TECHNOLOGIES INC.Inventor: Gregory Smith
-
Publication number: 20080033398Abstract: A device and a method are provided to enhance an immune response to a vaccine or immunogen by electrical stimulation of a biological interface in conjunction with administration of the vaccine or immunogen.Type: ApplicationFiled: December 28, 2006Publication date: February 7, 2008Applicant: TRANSCUTANEOUS TECHNOLOGIES INC.Inventors: Steven Reed, Rhea Coler
-
Publication number: 20080027369Abstract: An iontophoresis device includes an active electrode element operable to provide an electrical potential; an electrolyte reservoir comprising an electrolyte composition; an outer active agent membrane comprising a cross-linked polyelectrolyte gel and distributed in said gel, an interfacial layer having a first side adjacent to the outer active agent membrane, and an active agent of a first polarity.Type: ApplicationFiled: December 29, 2006Publication date: January 31, 2008Applicant: TRANSCUTANEOUS TECHNOLOGIES INC.Inventors: Darrick Carter, Gregory Smith
-
Publication number: 20080004564Abstract: This disclosure includes a device comprising a controlled release membrane comprising an electroactive polymer as well as methods of use thereof. In some particular embodiments, the electroactive polymer membrane is utilized in an active agent delivery device comprising a passive or active transport mechanism, including iontophoresis. In certain aspects, an iontophoresis device may be used which includes an active electrode assembly having an active agent solution holding portion; and a non-active electrode assembly. In certain aspects, the electroactive polymer membrane may be cycled from neutral state to charged state, thereby facilitating the administration of the active agent or pharmaceutical drug.Type: ApplicationFiled: March 30, 2007Publication date: January 3, 2008Applicant: TRANSCUTANEOUS TECHNOLOGIES INC.Inventor: Gregory Smith
-
Publication number: 20070213652Abstract: The present invention comprises an active agent reservoir that stores a quantity of an active agent, an active electrode element operable to apply an electrical potential of a first polarity to deliver at least a portion of the active agent to a biological interface from the iontophoresis device, and a communications port providing a communications path between the iontophoresis device and a remote device. A method of the invention comprises operating an interface system to remotely interact with iontophoresis devices useful in delivery of active agents to biological interfaces including providing a user interface at a location remote from at least some of the iontophoresis devices, communicating with at least two of the iontophoresis devices, and providing information about the iontophoresis devices via the user interface.Type: ApplicationFiled: December 28, 2006Publication date: September 13, 2007Applicant: TRANSCUTANEOUS TECHNOLOGIES INC.Inventor: Darrick Carter
-
Publication number: 20070197955Abstract: An iontophoresis device may include: an electric power source; a first electrode assembly coupled to the electric power source; and a second electrode assembly as a counter electrode of the first electrode assembly. The first electrode assembly may include an adhesive portion that facilitates contact between a mucous membrane and the first electrode assembly. The adhesive portion may be placed on a portion of an end surface portion of an electrode assembly, and may be made from a material that exhibits adhesiveness after absorbing an aqueous medium.Type: ApplicationFiled: October 12, 2006Publication date: August 23, 2007Applicant: TRANSCUTANEOUS TECHNOLOGIES INC.Inventors: Hidero Akiyama, Mizuo Nakayama, Takehiko Matsumura, Akihiko Matsumura
-
Publication number: 20070110810Abstract: Systems, devices, and methods for transdermal delivery of one or more therapeutic active agents to a biological interface. An iontophoretic drug delivery system is provided for transdermal delivery of one or more therapeutic active agents to a biological interface of a subject. The iontophoretic drug delivery system includes at least one active agent reservoir. In some embodiments, the at least one active agent reservoir include a backbone modified hydrogel matrix for incorporation one or more active agents.Type: ApplicationFiled: September 27, 2006Publication date: May 17, 2007Applicant: Transcutaneous Technologies Inc.Inventor: Gregory Smith
-
Publication number: 20070112294Abstract: An iontophoresis device may be capable of preventing the generation of gas or ions upon energization, and/or may be capable of preventing the alteration of active agent ions due to an electrode reaction. Energization from an electrode to an active agent reservoir may be performed through an ionic liquid. The ionic liquid may include an anion such as PF6-, BF4-, AlCl4-, ClO4-, a hydrogen sulfate ion, bis-trifluoro-alkyl-sulfonyl-imide, or trifluoro-methane-sulfonate, and a cation such as an imidazolium derivative, a pyridinium derivative, a piperidinium derivative, a pyrolidinium derivative, and a tetra-alkyl-ammonium derivative.Type: ApplicationFiled: September 14, 2006Publication date: May 17, 2007Applicant: Transcutaneous Technologies Inc.Inventors: Hidero Akiyama, Kiyoshi Kanamura, Mizuo Nakayama, Takehiko Matsumura, Akihiko Matsumura
-
Publication number: 20070093787Abstract: An iontophoresis device includes active and counter electrode assemblies. The active electrode assembly includes an active electrode element and at least two laterally spaced active agent reservoirs. The active electrode assembly may also include an outermost ion selective membrane caching an active agent and a further active agent carried by an outer surface of the outermost ion selective membrane. The active electrode assembly may also include an electrolyte reservoir storing electrolyte and an inner ion selective membrane positioned between the electrolyte reservoir and the active agents. The active electrode may also include an inner withdrawable sealing liner between the electrolyte reservoir and the active agents. An outer release liner may protectively cover or overlay the further active agent and/or outer surface prior to use. The active electrode assembly may also include a blister pack of at least two hydrating agent blisters to selectively hydrate dehydrated active agent.Type: ApplicationFiled: September 29, 2006Publication date: April 26, 2007Applicant: Transcutaneous Technologies Inc.Inventor: Gregory Smith
-
Publication number: 20070093789Abstract: An iontophoresis device includes an active electrode assembly including an active electrode element and at least one active agent reservoir. Active agents include one or more angiogenic growth factors suitable to promote or enhance healing or repair of injured or damaged tissue.Type: ApplicationFiled: September 29, 2006Publication date: April 26, 2007Applicant: Transcutaneous Technologies Inc.Inventor: Gregory Smith
-
Publication number: 20070088332Abstract: Contamination between an active agent solution in an active agent reservoir and an electrolyte solution in an electrolyte solution reservoir may be reduced in an iontophoresis device, thus helping to suppress the generation of gas and helping to reduce changes in pH upon energization. A gel matrix that transforms into a liquid state upon thermal excitation and/or mechanical excitation may be used in one or more reservoirs in the iontophoresis device.Type: ApplicationFiled: August 22, 2006Publication date: April 19, 2007Applicant: Transcutaneous Technologies Inc.Inventors: Hidero Akiyama, Mizuo Nakayama, Takehiko Matsumura, Akihiko Matsumura
-
Publication number: 20070088331Abstract: Whether or not a prescribed active agent is properly used may be confirmed. Usage of an active agent to be administered by an active agent injecting device (such as an iontophoresis device) driven by a drive signal may managed through a server based on actual drive information from the active agent injecting device.Type: ApplicationFiled: August 18, 2006Publication date: April 19, 2007Applicant: Transcutaneous Technologies Inc.Inventors: Mizuo Nakayama, Takehiko Matsumura, Hidero Akiyama, Akihiko Matsumura
-
Publication number: 20070083147Abstract: An iontophoresis device operable to deliver active agent to a biological interface such as skin or mucous membranes includes the combination of a hydrogel-based wound covering with an iontophoresis device to deliver antibiotic to biological interfaces. The effective concentration of antibiotics from oral or intravenous administration rarely reaches poorly perfused tissues such as cartilage or skin ulcerations resulting in entrenched and difficult to treat infections. Local deliver of additional antibiotic would serve to maintain the effective concentration of drug to the target tissues. Combining an iontophoresis device with a hydrogel-based wound covering to deliver localized antibiotic allows faster wound healing and prevent infection.Type: ApplicationFiled: October 2, 2006Publication date: April 12, 2007Applicant: Transcutaneous Technologies Inc.Inventor: Gregory Smith
-
Publication number: 20070078375Abstract: An iontophoresis device is provided to delivery active agents to a biological interface, the iontophoresis device comprising: an active electrode element operable to provide an electrical potential; and an inner active agent reservoir comprising a plurality of nanoparticles, each nanoparticles being conjugated to a plurality of active agents via respective linkers.Type: ApplicationFiled: September 28, 2006Publication date: April 5, 2007Applicant: Transcutaneous Technologies Inc.Inventor: Gregory Smith
-
Publication number: 20070078374Abstract: An iontophoresis device is provided for the delivery of active agents encapsulated in vesicles such as transferosomes and niosomes to a biological interface such as skin or mucous membranes.Type: ApplicationFiled: September 28, 2006Publication date: April 5, 2007Applicant: Transcutaneous Technologies Inc.Inventor: Gregory Smith
-
Publication number: 20070074590Abstract: An active agent delivery device is operable to deliver an active agent such as a drug or therapeutic agent to a biological interface such as skin or mucous membrane. The device, such as an iontophoresis device, may include one or more human-perceptible indicators operable to provide an indication of a malfunction or other defective condition of the device. Detectors may be provided to detect a value of a characteristic or parameter associated with one or more components of the device, with the value being usable to determine whether a defective condition may exist.Type: ApplicationFiled: September 25, 2006Publication date: April 5, 2007Applicant: Transcutaneous Technologies Inc.Inventor: Gregory Smith
-
Publication number: 20070066930Abstract: An iontophoresis device and method of producing the same may reduce material loss during the course of production of a conventional iontophoresis device, and may allow for easy automation of production processes and increases in production scale. The iontophoresis device may be used for administering drug ions of a first polarity generated by dissociation of a drug to a living body, and may comprise: a first conductive layer formed on a surface of a first substrate; a drug layer made of a drug coating containing the drug, the drug layer being laminated on the first conductive layer; and a first ion exchange layer made of an ion exchange coating containing an ion exchange resin having an exchange group introduced thereto, the ion exchange group having a counter ion to the first polarity ions, the first ion exchange layer being laminated on the drug layer.Type: ApplicationFiled: June 20, 2006Publication date: March 22, 2007Applicant: Transcutaneous Technologies, Inc.Inventors: Akihiko Tanioka, Akihiko Matsumura, Takehiko Matsumura, Mizuo Nakayama, Hidero Akiyama
-
Publication number: 20070066931Abstract: An iontophoresis device may be capable of preventing or reducing the generation of gas, or the production of undesirable ions, due to an electrode reaction occurring in an electrode assembly; or the alteration of an active agent due to a chemical reaction upon energization. A doping layer made of a substance such as a conductive polymer that effects an electrochemical reaction due to the doping or de-doping of an ion, may be formed in an electrode in an active electrode assembly or counter electrode assembly of an iontophoresis device.Type: ApplicationFiled: August 7, 2006Publication date: March 22, 2007Applicant: Transcutaneous Technologies Inc.Inventors: Kiyoshi Kanamura, Takehiko Matsumura, Mizuo Nakayama, Hidero Akiyama, Akihiko Matsumura